Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 6Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Peritoneal Neoplasms 1Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation 1Multiple Myeloma 1Lymphoma 1Hematologic Neoplasms 1Breast Neoplasms 1Advanced Solid Tumor 1Advanced Malignancies 1

Interventions

ulixertinib 1tislelizumab 1talazoparib 1serabelisib 1sapanisertib 1pembrolizumab 1olaparib 1mirdametinib 1lenvatinib 1erdafitinib 1crenigacestat 1atezolizumab 1Ramucirumab 1Paclitaxel 1PM 01183 1Injections 1IFL protocol 1Gemcitabine 1Bosentan 1BID protein, human 1Appointments and Schedules 11-dodecylpyridoxal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Advanced Solid Tumor × 1-dodecylpyridoxal × Clear all
NCT02644278 2019-09-09

First-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With Chemotherapy

EMD Serono

Phase 1 Completed
15 enrolled 13 charts
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡